Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $371.5700 (3.33%) ($355.6100 - $372.4400) on Wed. Jul. 6, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.3% (three month average) | | RSI | 49 | | Latest Price | $371.5700(3.33%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 1.8% a day on average for past five trading days. | | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(63%) XLV(50%) XBI(46%) IVW(40%) IWF(40%) | | Factors Impacting REGN price | REGN will decline at least -1.15% in a week (0% probabilities).
VIXM(-10%) UUP(-8%) TLT(-7%) IPO(-6%) IBUY(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.15% (StdDev 2.3%) | | Hourly BBV | 0 () | | Intraday Trend | 3.8% | | | | | |
|
| 5 Day Moving Average | $357.35(3.98%) | | 10 Day Moving Average | $351(5.86%) | | 20 Day Moving Average | $357.9(3.82%) | | To recent high | -13% | | To recent low | 12.2% | | Market Cap | $39.397b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |